FindTrial
Sign In

difference between post operative analgesic effect of caudal epidural injection of ropivacaine and fentanyl with ropivacaine alone in lumbo- sacral spine surgery.

â??Comparative analysis of postoperative analgesic effect of caudal epidural injection of ropivacaine and fentanyl with ropivacaine alone in lumbosacral spine surgeries- A randomized single blinded studyâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039415
Enrollment
56
Registered
2022-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G628- Other specified polyneuropathies

Interventions

Intervention1: caudal epidural block: caudal epidural block will be given, after patient positioning in prone position. block will be given ultrasound guided.in group A ropivacaine 0.2% 20ml Control I

Sponsors

AIIMS Raipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for lumbosacral spine surgery. 2. Patients age between 18 years to 65years. 3. Patient with ASA grade 1 and 2 with both the sexes.

Exclusion criteria

Exclusion criteria: 1. Patient not willing for consent 2. Patients with uncontrolled hypertension, diabetes or asthma. 3. Patients with preoperative opioid consumption. 4. Patients who underwent a previous lumber spine surgery. 5. Patients with contraindication to regional anaesthesia. 6. Patients with hypersensitive to ropivacaine and fentanyl. 7. Any lumbosacral anomaly

Design outcomes

Primary

MeasureTime frame
i. To evaluate and compare the analgesic effect of caudal epidural injection of ropivacaine and fentanyl with ropivacaine postoperatively (in terms of reduction in requirement of rescue analgesia). ii. To assess the duration and quality of analgesia (in term of first rescue analgesia and VAS score) iii. To see the incidence of any adverse effects. Timepoint: 1year 6 months—

Secondary

MeasureTime frame
ii. To assess the duration and quality of analgesia (in term of first rescue analgesia and VAS score) iii. To see the incidence of any adverse effects.Timepoint: 1YEAR 6MONTHS—

Countries

India

Contacts

Public ContactDr Rashmi Dubey

AIIMS Raipur

rajwadesuresh@gmail.com8305392756

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026